StockData

Incyte vs BeOne Medicines

INCY and ONC side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How INCY and ONC compare

BeOne Medicines is the larger company, worth 25 times as much as Incyte ($611B against $24.3B).

On earnings, Incyte is cheaper: it trades at 63.3× trailing earnings, against 961× for BeOne Medicines.

BeOne Medicines grew revenue faster over the last twelve months (34.3% versus 24.9% for Incyte).

BeOne Medicines keeps more of each dollar of sales as profit, with a net margin of 10.7% compared with 6.7% at Incyte.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricINCYONC
Size and price
Market cap$24.3B$611B
Share price$119.09$413.26
Change, 1 year14.3%13.0%
Change, 5 years74.2%18.9%
Beta (5Y)0.200.64
Employees2,84412K
StockData Score
Total score1313
Valuation score00
Growth score44
Performance score34 (better)
Health score6 (better)5
Dividend score00
Valuation
P/E63.3× (better)961×
P/S4.0× (better)99.7×
P/B4.3× (better)118×
EV/EBITDA29.0× (better)563×
P/FCF–459×
PEG1.03–
FCF yield–0.22%
Fair value$62.34$15.47
Margin of safety−91.0% (better)−2571%
Growth
Revenue growth (TTM)24.9%34.3% (better)
Revenue growth, 5Y average14.0%76.8% (better)
Net income growth (TTM)−66.1%–
EPS growth (TTM)−68.2%–
Profitability
Gross margin92.7% (better)88.9%
Operating margin10.4%15.1% (better)
Net margin6.7%10.7% (better)
FCF margin–21.7%
Return on equity7.8%14.7% (better)
Return on invested capital13.9%43.7% (better)
Financial health
Debt / equity0.000.22 (better)
Net debt / EBITDA–−3.67
Interest coverage268× (better)8.7×
Current ratio3.84 (better)3.40
Altman Z-score10.7092.06 (better)
Piotroski F-score8 (better)7
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions99.4%2.4%
Held by insiders33.2%14.2%
Insider net buying, 12 months−$66.0M (better)−$384M
Short interest, % of float7.8%–

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.